"we had (borrelia miyamotoi) as the new disease for the physicians to be aware of", told rusk...
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
shocking figures uncovered by labour show some patients are suffering agonising waits of as many as 541 days to begin treatment.